You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ABAMETAPIR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ABAMETAPIR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01518699 ↗ Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers Completed Dr. Reddy's Laboratories Limited Phase 1 2012-01-01 The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
NCT01518699 ↗ Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers Completed Hatchtech Pty Ltd Phase 1 2012-01-01 The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
NCT02060903 ↗ A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Completed Accelovance Phase 3 2014-02-01 The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ABAMETAPIR

Condition Name

Condition Name for ABAMETAPIR
Intervention Trials
Head Lice Infestation 3
Head Lice 2
Pediculosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ABAMETAPIR
Intervention Trials
Lice Infestations 4
Mite Infestations 3
Parasitic Diseases 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ABAMETAPIR

Trials by Country

Trials by Country for ABAMETAPIR
Location Trials
United States 16
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ABAMETAPIR
Location Trials
New Jersey 2
Tennessee 2
Florida 2
California 2
Utah 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ABAMETAPIR

Clinical Trial Phase

Clinical Trial Phase for ABAMETAPIR
Clinical Trial Phase Trials
Phase 3 2
Phase 2 1
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ABAMETAPIR
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ABAMETAPIR

Sponsor Name

Sponsor Name for ABAMETAPIR
Sponsor Trials
Dr. Reddy's Laboratories Limited 6
Hatchtech Pty Ltd 6
Accelovance 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ABAMETAPIR
Sponsor Trials
Industry 16
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.